Prophylactic amrinone for weaning from cardiopulmonary bypass

Anaesthesia

Volumn 55, Issue 7, 2000, Pages 627-633

  Lewis, K P ^a   Appadurai, I R ^b   Pierce, E T ^a   Halpern, E F ^c   Bode Jr , R H ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Heart; Pharmacology: amrinone; Surgery: cardiovascular

Indexed keywords

AMRINONE; ANGIOTENSIN ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; NITRATE;

ADULT; AGED; ANESTHESIOLOGICAL TECHNIQUES; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; ELECTIVE SURGERY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PRESERVATION; HEMODYNAMIC MONITORING; HUMAN; MALE; PROPHYLAXIS; VALVULAR HEART DISEASE; WEANING;

AGED; AMRINONE; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; STROKE VOLUME; VASODILATOR AGENTS;

EID: 0033922399     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.2000.01372.x     Document Type: Article

References (20)

1. Edmunds LH, Stephenson LW, Edie RN. Open-heart surgery in octogenarians. New England Journal of Medicine 1988; 319: 131-6.
2. Lewis KP. Early intervention of inotropic support in facilitating weaning from cardiopulmonary bypass: the New England Deaconess Hospital experience. Journal of Cardiothoracic and Vascular Anesthesia 1993; 7 (Suppl. 2): 40-5.
3. Yusuf S, Teo K. Inotropic agents increase mortality in patients with congestive heart failure. Circulation 1990; 82: 673(Abstract).
4. Packer M, Medina N, Yushak M. Hemodynamic and clinical limitation of long-term inotropic therapy with amrinone in patients with severe chronic heart failure. Circulation 1984; 70: 1038-49.
5. Royster RL, Butterworth JF IV, Prough DS, et al. Preoperative and intraoperative predictors of inotropic support and long-term outcome in patients having coronary artery bypass grafting. Anesthesia and Analgesia 1991; 72: 729-36.
6. Fogg KJ, Royston D. Improved performance with single dose phosphodiesterase inhibitor? British Journal of Anaesthesia 1998; 81: 663-6.
7. Sandler H, Dodge HT. The use of single plane angiocardiograms for the calculation of left ventricular volume in man. American Heart Journal 1968; 75: 325-34.
8. Landis RJ, Heyman ER, Koch GG. Average partial association in three-way contingency tables: a review and discussion of alternative tests. International Statistical Review 1978; 46: 237-54.
9. Satterthwaite FW. An approximate distribution of estimates of variance components. Biometrics Bulletin 1946; 2: 110-14.
10. Fita G, Gomar C, Jiminez MJ, Pacheco M, Mulet J, Nalda MA. Amrinone in perioperative low cardiac output syndrome. Acta Anaesthesiologica Scandinavica 1990; 34: 482-5.
11. Hardy JF, Searle N, Roy ML, Perrault J. Amrinone, in combination with norepinephrine, is an effective first-line drug for difficult separation from cardiopulmonary bypass. Canadian Journal of Anaesthesia 1993; 40: 495-501.
12. Lathi KG, Shuhnan MS, Diehl JT, Stetz JJ. The use of amrinone and norepinephrine for inotropic support during emergence from cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia 1991; 5: 250-4.
13. Royster RL, Butterworth JF IV, Prielipp RC, et al. Combined inotropic effects of amrinone and epinephrine after cardiopulmonary bypass in humans. Anesthesia and Analgesia 1993; 77: 662-72.
14. Dupuis J-Y, Bondy R, Cattran C, et al. Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery: a comparison of their effects on hemodynamics and outcome. Journal of Cardiothoracic and Vascular Anesthesia 1992; 6: 542-53.
15. Salmenpera M, Levy JH. The in vitro effects of phosphodiesterase inhibitors on the human internal mammary artery. Anesthesia and Analgesia 1996; 82: 954-7.
16. Royster RC, Whiteley SW, Butterworth JF IV. Amrinone therapy during emergence from cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery 1991; 101: 942-3.
17. Ramsay JG, DeJesus JM, Wynands JE, et al. Amrinone before termination ot cardiopulmonary bypass: haemodynamic variables and oxygen utilization in the postbypass period. Canadian Journal of Anaesthesia 1992; 39: 342-8.
18. Bailey JM, Levy JH, Rogers HC, Szlam F, Hug CC. Pharmacokinetics of amrinone during cardiac surgery. Anesthesiology 1991; 75: 961-8.
19. Badner NH, Murkin JM, Shannon NA. An amrinone bolus prior to weaning from cardiopulmonary bypass improves cardiac function in mitral valve surgery patients. Journal of Cardiothoracic and Vascular Anesthesia 1994; 8: 410-14.
20. Butterworth JF IV, Royster RL, Prielipp RC, et al. Amrinone in cardiac surgical patients with left-ventricular dysfunction. A prospective, randomized placebo-controlled trial. Chest 1993; 104: 1660-7.